Filing Details
- Accession Number:
- 0000899243-21-022025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-04 16:16:57
- Reporting Period:
- 2021-06-03
- Accepted Time:
- 2021-06-04 16:16:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815442 | Kymera Therapeutics Inc. | KYMR | Biological Products, (No Disgnostic Substances) (2836) | 812992166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821074 | N. Bruce Jacobs | C/O Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-03 | 10,000 | $2.08 | 17,256 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-03 | 5,506 | $46.66 | 11,494 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-03 | 4,494 | $47.13 | 7,256 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-06-03 | 10,000 | $0.00 | 10,000 | $2.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 219,899 | 2029-08-28 | No | 4 | A | Direct |
Footnotes
- This number includes 256 shares acquired under the Registrant's employee stock purchase plan for the period ended May 31, 2021.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.93 to $46.92. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.93 to $47.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Twenty-five percent (25%) of the shares underlying this stock option vested on July 1, 2020 and the remaining shares shall vest in equal monthly installments over the remaining thirty-six (36) months, subject to the reporting person's continued employment through each vesting date.
Billionaire Hedge Funds
